Insulin-like Growth Factor II (IGF II) in Human Brain: Regional Distribution of IGF II and of Higher Molecular Mass Forms

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1985 Apr 1

PMID 3885223

Citations 31

Authors

G K Haselbacher

M E Schwab

A Pasi

R E HUMBEL

Affiliations

Soon will be listed here.

Abstract

Twenty-four distinct areas of human brain were analyzed for the presence of insulin-like growth factor (IGF). As reported for cerebrospinal fluid, only IGF II-like immunoreactivity, but no significant amounts of IGF I-like immunoreactivity, could be found. Upon gel permeation chromatography, two to five distinct size classes were separated on the basis of their immunoreactivity. The smallest component had an apparent molecular mass of 7.5 kDa, identical to the one of purified IGF II from human serum. Radioimmunoassays and a bioassay also gave results indistinguishable from those of serum IGF II. The highest amounts of IGF II-like immunoreactivity occur in the anterior pituitary--namely, 20-25 pmol equivalents/g of wet weight. This is up to 100 times more than in most other brain regions analyzed. The higher molecular mass immunoreactive species were partially characterized. After immunoaffinity purification, the 38- and 26-kDa species are active in a bioassay. Specific IGF-binding protein activity could be shown after purification of the 38- and 26-kDa species on an IGF-affinity column. The 13-kDa species released significant amounts of 7.5-kDa material. The results are interpreted as evidence for the presence of IGF II synthesized locally in human brain. The structure of the larger forms of IGF II-like immunoreactive material as well as the function of IGF II in brain are not yet known.

Citing Articles

Insulin-Like Growth Factor 2 As a Possible Neuroprotective Agent and Memory Enhancer-Its Comparative Expression, Processing and Signaling in Mammalian CNS.

Beletskiy A, Chesnokova E, Bal N Int J Mol Sci. 2021; 22(4).

PMID: 33673334 PMC: 7918606. DOI: 10.3390/ijms22041849.

Insulin-like growth factor-II and bioactive proteins containing a part of the E-domain of pro-insulin-like growth factor-II.

van Doorn J Biofactors. 2020; 46(4):563-578.

PMID: 32026557 PMC: 7497164. DOI: 10.1002/biof.1623.

Insulin-like growth factors and related proteins in plasma and cerebrospinal fluids of HIV-positive individuals.

Suh H, Lo Y, Choi N, Letendre S, Lee S J Neuroinflammation. 2015; 12:72.

PMID: 25890304 PMC: 4407382. DOI: 10.1186/s12974-015-0288-6.

Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators.

Suh H, Zhao M, Derico L, Choi N, Lee S J Neuroinflammation. 2013; 10:37.

PMID: 23497056 PMC: 3607995. DOI: 10.1186/1742-2094-10-37.

Promoter-specific expression and imprint status of marsupial IGF2.

Stringer J, Suzuki S, Pask A, Shaw G, Renfree M PLoS One. 2012; 7(7):e41690.

PMID: 22848567 PMC: 3405008. DOI: 10.1371/journal.pone.0041690.

References

Daughaday W, Hall K, RABEN M, SALMON Jr W, VAN DEN BRANDE J, Van Wyk J . Somatomedin: proposed designation for sulphation factor. Nature. 1972; 235(5333):107. DOI: 10.1038/235107a0. View

Rinderknecht E, HUMBEL R . Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proc Natl Acad Sci U S A. 1976; 73(7):2365-9. PMC: 430569. DOI: 10.1073/pnas.73.7.2365. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Rinderknecht E, HUMBEL R . Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain. Proc Natl Acad Sci U S A. 1976; 73(12):4379-81. PMC: 431462. DOI: 10.1073/pnas.73.12.4379. View

Furlanetto R, Underwood L, Van Wyk J, DErcole A . Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977; 60(3):648-57. PMC: 372409. DOI: 10.1172/JCI108816. View

Rinderknecht E, HUMBEL R . Primary structure of human insulin-like growth factor II. FEBS Lett. 1978; 89(2):283-6. DOI: 10.1016/0014-5793(78)80237-3. View

Zapf J, Schoenle E, Jagars G, Sand I, Grunwald J, FROESCH E . Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest. 1979; 63(5):1077-84. PMC: 372051. DOI: 10.1172/JCI109377. View

Rechler M, Zapf J, NISSLEY S, FROESCH E, Moses A, Podskalny J . Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology. 1980; 107(5):1451-9. DOI: 10.1210/endo-107-5-1451. View

Zapf J, Morell B, Walter H, Laron Z, FROESCH E . Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh). 1980; 95(4):505-17. DOI: 10.1530/acta.0.0950505. View

10.

BINOUX M, Hossenlopp P, Lassarre C, Hardouin N . Production of insulin-like growth factors and their carrier by rat pituitary gland and brain explants in culture. FEBS Lett. 1981; 124(2):178-84. DOI: 10.1016/0014-5793(81)80131-7. View

11.

Zapf J, Walter H, FROESCH E . Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest. 1981; 68(5):1321-30. PMC: 370928. DOI: 10.1172/jci110379. View

12.

Vassilopoulou-Sellin R, Phillips L . Extraction of somatomedin activity from rat liver. Endocrinology. 1982; 110(2):582-9. DOI: 10.1210/endo-110-2-582. View

13.

Zapf J, FROESCH E, HUMBEL R . The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul. 1981; 19:257-309. DOI: 10.1016/b978-0-12-152819-5.50024-5. View

14.

Schoenle E, Zapf J, HUMBEL R, FROESCH E . Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature. 1982; 296(5854):252-3. DOI: 10.1038/296252a0. View

15.

Massague J, Czech M . The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J Biol Chem. 1982; 257(9):5038-45. View

16.

Haselbacher G, Humbel R . Evidence for two species of insulin-like growth factor II (IGF II and "big" IGF II) in human spinal fluid. Endocrinology. 1982; 110(5):1822-4. DOI: 10.1210/endo-110-5-1822. View

17.

Sara V, Uvnas-Moberg K, UVNAS B, Hall K, Wetterberg L, Posloncec B . The distribution of somatomedins in the nervous system of the cat and their release following neural stimulation. Acta Physiol Scand. 1982; 115(4):467-70. DOI: 10.1111/j.1748-1716.1982.tb07105.x. View

18.

Laubli U, Baier W, Binz H, Celio M, HUMBEL R . Monoclonal antibodies directed to human insulin-like growth factor I (IGF I). Use for radioimmunoassay and immunopurification of IGF. FEBS Lett. 1982; 149(1):109-12. DOI: 10.1016/0014-5793(82)81082-x. View

19.

Acquaviva A, Bruni C, NISSLEY S, Rechler M . Cell-free synthesis of rat insulin-like growth factor II. Diabetes. 1982; 31(7):656-8. DOI: 10.2337/diab.31.7.656. View

20.

Adams S, NISSLEY S, Handwerger S, Rechler M . Developmental patterns of insulin-like growth factor-I and -II synthesis and regulation in rat fibroblasts. Nature. 1983; 302(5904):150-3. DOI: 10.1038/302150a0. View